ArticlebioRxiv : the preprint server for biology2026
Single-cell hit calling in high-content imaging screens with Buscar.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
High-content screening (HCS) enables the systematic quantification of single-cell morphology features across thousands of perturbations, capturing rich phenotypic heterogeneity. Image-based profiling is a critical bioinformatics processing step in this pipeline, as researchers use it to predict mechanisms of action, assess toxicity, perform hit calling, and more. However, current image-based profiling workflows rely on aggregate statistics, such as calculating mean or median feature values per well, implicitly assuming cell homogeneity. This limitation obscures subpopulation effects, reducing sensitivity to subtle or heterogeneous effects of perturbations. Here we present Buscar, a method that leverages the full heterogeneity of single-cell image-based profiles to call hits. Buscar requires two reference, single-cell populations that define distinct morphology states: a reference state (e.g., disease cells) and a target state (e.g., healthy cells). Buscar then compares these two groups to define on- and off-morphology signatures, which it then uses to score every perturbation in a given screen. The scores quantify perturbation efficacy and off-target effects, or specificity, in an interpretable manner, clarifying which morphologies are appropriately altered and which may arise from off-target activity. We apply Buscar to three datasets. First, as a proof of concept, we applied Buscar to a Cell Painting dataset of cardiac fibroblasts from patients with heart failure. Buscar quantifies both morphology rescue and off-target morphology activity in these cells treated with a TGFβ receptor inhibitor. Second, we show that Buscar recovers biologically coherent gene-phenotype associations across 16 manually-labeled phenotypes in the MitoCheck dataset. Lastly, applied to CPJUMP1, we show that Buscar is robust to technical replicates collected across plates in both small-molecule and CRISPR-Cas9 perturbations. Together, these results establish Buscar as a reproducible and interpretable hit calling method that overcomes aggregation bias, enabling the simultaneous quantification of compound efficacy and specificity to enhance hit calling in HCS. We release Buscar as an open-source python package.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.